IXICO plc (PHYOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0700
-0.0800 (-53.33%)
At close: Jul 26, 2024
IXICO Revenue
In the fiscal year ending September 30, 2024, IXICO had annual revenue of 5.77M GBP, down -13.49%. IXICO had revenue of 3.23M in the half year ending September 30, 2024, a decrease of -31.62%.
Revenue
5.77M GBP
Revenue Growth
-13.49%
P/S Ratio
1.44
Revenue / Employee
71.19K GBP
Employees
81
Market Cap
11.09M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 5.77M | -899.00K | -13.49% |
| Sep 30, 2023 | 6.67M | -1.98M | -22.89% |
| Sep 30, 2022 | 8.64M | -547.00K | -5.95% |
| Sep 30, 2021 | 9.19M | -342.00K | -3.59% |
| Sep 30, 2020 | 9.53M | 1.97M | 26.07% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 20.65M |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
IXICO News
- 5 months ago - IXICO PLC (FRA:PYPB) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 5 months ago - Full Year 2024 IXICO PLC Earnings Call Transcript - GuruFocus
- 5 months ago - Small Cap Stocks: Eco Buildings, IXICO, Electric Guitar - The Armchair Trader